tm logo

Monitor this mark

View On USPTO

RYPLAZIM
Live/Registered
REGISTERED

on 10 Dec 2019

Last Applicant/ Owned by

KEDRION BIOPHARMA INC.

400 KELBY STREET, SUITE 1200

FORT LEE

NJ

07024

Serial Number

87247928 filed on 25th Nov 2016

Registration Number

5929628 registered on 10th Dec 2019

in the Principal Register

Correspondent Address

Lindsay Jones

Lindsay Jones Merchant & Gould P.C.

Minneapolis, MN 55402-0910

United States

Filing Basis

1. intent to use

Disclaimer

NO DATA

RYPLAZIM

Pharmaceutical preparations for the treatment of conditions associated with plasminogen deficiencies

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of conditions associated with plasminogen deficiencies

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 87247928

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 7587.763US01

44D Filed

No

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
10th Dec 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06th Dec 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
29th Nov 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
29th Nov 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
29th Nov 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
29th Nov 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
29th Nov 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
29th Nov 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10th Dec 2019REGISTERED-PRINCIPAL REGISTER
24th Sep 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED